Compounds > 7-hydroxystaurosporine
Page last updated: 2024-08-25

7-hydroxystaurosporine and Cancer of Prostate

7-hydroxystaurosporine has been researched along with Cancer of Prostate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alley, MC; Dasmahapatra, GP; Didolkar, P; Ghosh, S; Roy, KK; Sausville, EA1
Ferbeyre, G; Mukhopadhyay, UK; Senderowicz, AM1
Blagosklonny, MV; Dixon, SC; Figg, WD; Robey, R1

Other Studies

3 other study(ies) available for 7-hydroxystaurosporine and Cancer of Prostate

ArticleYear
In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-01, Volume: 10, Issue:15

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Female; Humans; Immunoblotting; Lung Neoplasms; Male; Phosphorylcholine; Prostatic Neoplasms; Signal Transduction; Staurosporine; Time Factors

2004
RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells.
    Cancer research, 2005, Apr-01, Volume: 65, Issue:7

    Topics: Antibiotics, Antineoplastic; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Diploidy; DNA Damage; DNA-Binding Proteins; Doxorubicin; Fibroblasts; G2 Phase; Gene Expression; Gene Silencing; Genes, cdc; Genes, p53; Humans; Male; Mutation; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Protein Serine-Threonine Kinases; RNA Interference; RNA, Catalytic; RNA, Neoplasm; RNA, Small Interfering; Staurosporine; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2005
Resistance to growth inhibitory and apoptotic effects of phorbol ester and UCN-01 in aggressive cancer cell lines.
    International journal of oncology, 2001, Volume: 18, Issue:4

    Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Neoplasm; Down-Regulation; Drug Resistance, Neoplasm; Formazans; Humans; Immunoblotting; Male; Prostatic Neoplasms; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Transfection; Tumor Cells, Cultured

2001